Medically Supervised Weight Loss

Weight loss injections are typically prescribed to adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have weight-related health conditions such as type 2 diabetes or high blood pressure.

Clinical trials have shown that medically supervised weight loss injections lead to significant weight loss in individuals with obesity or overweight. On average, participants lost more weight compared to those taking a placebo.

Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects often improve over time as the body adjusts to the medication.

Injections for weight loss is administered once weekly via subcutaneous injection. The dosage may be gradually increased over several weeks to minimize side effects.

Long-term safety data for weight loss is still being studied. However, it has been used for years in lower doses to treat type 2 diabetes, and its safety profile has been well-established in that context.

Combining injections with other weight loss medications or supplements should only be done under the guidance of a healthcare professional, as interactions and side effects may occur.

Weight regain is possible after discontinuing weight loss injection treatment, especially if lifestyle changes are not maintained. However, continued healthy eating and exercise habits can help maintain weight loss results.

Individual results may vary, but some people may start to see weight loss within a few weeks of starting treatment. Maximum weight loss typically occurs after several months of consistent use.

Coverage for weight loss injections may vary depending on insurance plans and individual circumstances. It’s recommended to check with your insurance provider to determine coverage and any associated costs.